
Programmable Viruses
We are developing a new kind of programmable viral vector that can be targeted to precisely defined cell types throughout the body. We are testing our vectors for use in gene therapy and cancer therapy, with greater efficacy and reduced side-effects compared to existing solutions.
Category
Viral Vectors
People
Daniele Cervettini
Bhuvana Sudarshan
Collaborators
Milestones
2021: Project launched
2022: Grant obtained ($2,000,000 USD)